Trial intelligence / Profile preview

N-acetyl Cysteine Adjuvant to Ovarian Drilling in PCOS

NCT02239107Phase 4Completed

Sponsor
Assiut University
Start
Jan 2012
Primary completion
Dec 2013
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of acetylcysteine in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Assiut University. Primary endpoint: Ovulation rate at 6 months. Started Jan 2012; status: completed.

02

Drugs

acetylcysteine
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02239107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02239107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call